Verification of Novel Survival Prediction Algorithm for Patients With NSCLC Spinal Metastasis

Clinical trial NCT03363685 · UNKNOWN

Trial details

NCT number: NCT03363685
Sponsor: Ruijin Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Spinal Metastases Non-Small-Cell Lung Cancer Metastatic

Start date: 2017-11-01
Primary completion: 2022-11-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.